State Street SPDR S&P Pharmaceuticals ETF (XPH) — ()
Key Metrics
News
XPH: Healthcare Dashboard For January
Published: by:
Sentiment: Positive ()
Healthcare providers have a good value score, and the pharmaceuticals & biotechnology subsector has a good quality score. State Street SPDR S&P Pharmaceuticals ETF provides modified equal-weighted exposure to the …
Read More
US and UK agree zero-tariffs on pharmaceuticals
Published: by:
Sentiment: Positive ()
The US has agreed to spare the UK from threatened trade tariffs on pharmaceutical products.
Read More
XPH: Small-Cap Pharma Turns Higher, At Long Last
Published: by:
Sentiment: Positive ()
SPDR S&P Pharmaceuticals ETF is rated a "Buy" due to compelling valuation and improving technical momentum. XPH offers diversified exposure to large-, mid-, and small-cap pharma stocks, balancing blue-chip stalwarts …
Read More
Trump Trade War: New Tariffs on Drugs, Trucks, and Furniture Raise Inflation Risks
Published: by:
Sentiment: Negative ()
President Trump's new tariffs on drugs, trucks, and furniture reignite trade tensions, boosting U.S. manufacturers but raising global costs, pressuring exporters, and adding inflation risks.
Read More
Trump announces 100% tariffs on pharmaceutical drugs, beginning October 1
Published: by:
Sentiment: Negative ()
President Donald Trump said Thursday that he will put import taxes of 100% on pharmaceutical drugs, 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture and 25% on …
Read More
Pharma stocks gain, as Trump's tariff move actually could be a win for the sector
Published: by:
Sentiment: Positive ()
Pharmaceutical stocks mostly gained Friday, as traders appeared to shrug off or even cheer President Donald Trump's rollout of a new tariff plan for drugmakers.
Read More
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit
Published: by:
Sentiment: Negative ()
Trump's 100% tariff on imported drugs jolts markets, slamming pharma giants and dragging ETFs like XPH, FTXH, IHE, and PPH lower.
Read More
ETFs on the Move Post U.S.-China Trade Deal
Published: by:
Sentiment: Positive ()
Let's delve into the ETF world following the 90-day U.S.-China trade deal.
Read More
A Look at Pharma ETFs After Strong Q1 Earnings
Published: by:
Sentiment: Positive ()
Many pharma bigwigs reported solid results, with some beating on earnings or revenues or both.
Read More